Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.

Simple item page
dc.contributor.authorFryauff, D. J.,
dc.contributor.authorOwusu-Agyei, S.
dc.contributor.authorUtz, G.
dc.contributor.authorBaird, J. K
dc.contributor.authorKoram, K.A.
dc.contributor.authorBinka, F.
dc.contributor.authorNkrumah, F.
dc.contributor.authorHoffman, S. L.
dc.date.accessioned2013-06-26T18:41:08Z
dc.date.accessioned2017-10-16T12:58:33Z
dc.date.available2013-06-26T18:41:08Z
dc.date.available2017-10-16T12:58:33Z
dc.date.issued2007-02
dc.description.abstractMefloquine (MQ) single dose 20 mg/kg treatment of falciparum malaria was evaluated in 186 children of 6-24 months of age in northern Ghana. There were 15 RII/RIII-type parasitologic failures, all with Day 2 MQ blood levels significantly lower than children whose parasitemias cleared before Day 7 and remained clear through 28 days. Predictors of RII/RIII parasitologic response were vomiting after MQ dosing, Day 2 MQ levels < 500 ng/mL, and undetectable Day 2 levels of the carboxymefloquine metabolite. There were 50 cases of delayed RI parasitologic failure, but 71% of these cases had undetectable Day 28 blood levels of MQ and drug levels in the remaining 29% ranged below the 620 ng/mL level that suppresses MQ sensitive strains of P. falciparum. Drug levels among infants that tolerated MQ well were not associated with age, weight, hemoglobin, parasitemia, and pre-existing symptoms of vomiting or diarrhea. An observed recurrent parasitemia of 34,400 trophozoites/μL against a MQ blood concentration of 550 ng/mL was taken as indication of tolerance to suppressive levels of the drug at this location. Copyright © 2007 by The American Society of Tropical Medicine and Hygiene.en_US
dc.identifier.citationFryauff, D. J., Owusu-Agyei, S., Utz, G., Baird, J. K., Koram, K. A., Binka, F., . . . Hoffman, S. L. (2007). Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana. American Journal of Tropical Medicine and Hygiene, 76(2), 224-231.en_US
dc.identifier.issn00029637
dc.identifier.urihttp://197.255.68.203/handle/123456789/4205
dc.language.isoenen_US
dc.subjectEMTREE drug terms: hemoglobin; mefloquine; antimalarial agent EMTREE medical terms: article; controlled study; drug blood level; drug tolerability; female; Ghana; human; infant; major clinical study; malaria falciparum; male; parasitemia; preschool child; single drug dose; treatment failure; animal; blood; chemically induced disorder; clinical trial; cohort analysis; diarrhea; growth, development and aging; parasitology; Plasmodium falciparum; prospective study; statistical model; vomitingen_US
dc.titleMefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.en_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana..pdf
Size:
350.32 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Parasitology Department